← Back to Search

Procedure

SuperNO2VA™EtCO2 (Nasal Oxygenating Ventilating Apparatus) for Obstructive Sleep Apnea

N/A
Waitlist Available
Led By Erikka Washington, MD
Research Sponsored by The University of Texas Health Science Center, Houston
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up end of procedure
Awards & highlights

Study Summary

This trial will compare the effects of two different methods of oxygenation and ventilation on obese patients during colonoscopy.

Eligible Conditions
  • Obstructive Sleep Apnea, Obesity

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~prior to endoscopic intubation,during the procedure
This trial's timeline: 3 weeks for screening, Varies for treatment, and prior to endoscopic intubation,during the procedure for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Time taken from initiation of induction to the first airway intervention
Secondary outcome measures
Amount of propofol administered during induction
Anesthesiologist satisfaction score as assessed by the visual analog scale (VAS)
Change in alertness of subject as assessed by the Modified Observer's Assessment of Alertness/Sedation Scale (MOAAS)
+13 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Group B: SuperNO2VA™EtCO2Experimental Treatment1 Intervention
Group II: Group A: Standard care with a facemask.Active Control1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
SuperNO2VA™EtCO2 (Nasal Oxygenating Ventilating Apparatus)
2022
N/A
~140

Find a Location

Who is running the clinical trial?

The University of Texas Health Science Center, HoustonLead Sponsor
903 Previous Clinical Trials
320,838 Total Patients Enrolled
Vyaire MedicalIndustry Sponsor
9 Previous Clinical Trials
885 Total Patients Enrolled
Erikka Washington, MDPrincipal InvestigatorThe University of Texas Health Science Center, Houston

Media Library

Nasal Positive Airway Pressure (Procedure) Clinical Trial Eligibility Overview. Trial Name: NCT05524220 — N/A
Obstructive Sleep Apnea Research Study Groups: Group A: Standard care with a facemask., Group B: SuperNO2VA™EtCO2
Obstructive Sleep Apnea Clinical Trial 2023: Nasal Positive Airway Pressure Highlights & Side Effects. Trial Name: NCT05524220 — N/A
Nasal Positive Airway Pressure (Procedure) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05524220 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies still available for participants in this experiment?

"This trial does not currently appear to be recruiting new participants, as the last edit was made on November 7th 2022. Despite this, clinicaltrials.gov lists 290 other trials that are actively looking for patients at this time."

Answered by AI

Who else is applying?

What state do they live in?
Texas
What site did they apply to?
The University of Texas Health Science Center at Houston
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
1
~62 spots leftby Apr 2025